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of chromosome aberration production
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Richard Dimbleby Department ofCancer Research, St. Thomas's Hospital Medical School, London SE] 7EH
Summary The induction of chromosome damage by the Platinum complex CHIP in Chinese
hamster ovary (CHO) cells has been studied, together with the relationship between cell survival
and aberration frequency. The type and frequency of chromosome aberrations observed in
asynchronous and G, phase treated cells indicated a similar mode of action to that of
bifunctional alkylating agents. A log-linear relationship was observed between the frequency of
chromatid aberrations (excluding gaps) and the level of survival after CHIP treatment, with
approximately one aberration per cell corresponding to 37% survival.
Cis dichloro-bis (isopropylamine) trans dihydroxy
platinum IV-CHIP-is one of the new platinum
co-ordination complexes in the group of potential
antitumour agents, whose cytotoxic action has now
been studied extensively. It can be compared with
another platinum complex cis-dichloro-bis
(cyclopentylamine) platinum (II), PAD, which
although insoluble in water was found to have a
high antitumour activity and a large therapeutic
index (235), (Connors et al., 1972). In contrast,
CHIP is highly water soluble and this has
encouraged further investigation into its mode of
action.
Results from several workers indicate that DNA
is the primary intracellular target for the cytotoxic
action of the platinum complexes, where inter- and
intra-strand crosslinks are produced (Roberts &
Pascoe, 1972; Kelman et al., 1977). These effects of
platinum complexes on DNA point to a similar
mode of action to that observed with bifunctional
alkylating agents; i.e. the production of "delayed
type" chromosome aberrations as a result of DNA
synthesis on a damaged template (Bender et al.,
1974).
Studies were undertaken to examine this
possibility and to understand better the mechanism
underlying the cytotoxic action of CHIP. In this
paper the results of the investigation of the
production of chromosome aberrations by CHIP in
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Chinese hamster ovary (CHO) cells and the
relationship of these aberrations to cell killing are
presented.
Materials and methods
Cell culture
During the course of this work two aneuploid
clones of Chinese hamster ovary (CHO) cells were
used. Each had predominantly 23 chromosomes but
the parent clone H had more polyploid cells than
the subsequent sub-clone 10. Clone H showed
slightly less sensitivity to CHIP than clone 10,
with respect to the Dq values of their dose-response
curves (53pgml-1 and 27pgml-' respectively)
although the Do values were the same (19.4,ug
ml-1). Cells were cultured as a monolayer in
disposable plastic tissue-culture flasks (Nunclon) in
HEPES-buffered (25 mM) Ham's F12 medium
supplemented with 15% calf serum, non-essential
amino acids and 2 mM glutamine. No antibiotics
were used.
Cell survival
Survival of cells was determined by their colony
forming ability after 5 day's growth, as described
previously (Szumiel & Nias, 1976).
Synchrony
Synchronization was obtained by the mitotic
selection method (Terasima & Tolmach, 1963). The
degree of synchrony was estimated from the
measurement of the mitotic index immediately after
mitotic selection. This was usually between 85-95%.
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Platinum complex
Cis dichloro-bis (isopropylamine) trans dihydroxy
platinum IV (CHIP) was kindly supplied by
Johnson Mathey and Co. Ltd.
Drug treatment
In all experiments cells were exposed to CHIP in
culture medium for h at 37°C after they had
adhered to the surface of the flask. The stock
solution of drug was dissolved at a concentration of
mgml - in cold physiological saline and kept in
the dark. All drug preparations were freshly
prepared, immediately before each experiment.
After the cells were exposed for 1 h the drug-
containing medium was sucked off and replaced
with fresh medium.
Chromosome preparations and analysis
Colcemid at a final concentration of 1 ig ml- 1 was
used. Cells were hypotonized with 0.7% sodium
citrate solution for 7-13min at 37°C. Thereafter
cells were fixed and washed in three changes of a
3:1 mixture of absolute methyl alcohol and glacial
acetic acid, and microscopic preparations were
made. Preparations were air dried and stained with
10% Giemsa solution.
All types of chromatid aberrations were scored
separately and classified as chromatid and
isochromatid breaks and gaps, chromatid
exchanges, single fragments and chromatid
interstitial deletions. An aberration was classified as
a break where there was a displacement of a
chromatid fragment or where the distance between
two parts of chromatid arm was larger than the
diameter of the chromatid. Those cells exhibiting
numerous aberrations, in which an accurate
analysis was too difficult, were recorded as
multiaberration cells. Gaps were scored, although
there is some uncertainty about their significance
and they probably do not contribute to lethality.
Results
Chromosome aberration production by CHIP in
CHO clone H cells
An asynchronous population of CHO clone H cells
was used to determine the effects of treatment with
increasing concentrations of CHIP. After treatment
with the drug, cells were incubated for 6 h at 37°C.
Colcemid was added to the cultures during the last
2h of the experiment, before mitotic selection.
Mitotic cells harvested at this time were those
treated with the drug in the middle of the S phase.
(For duration of cell cycle, see Szumiel & Nias,
1976). Table I shows the frequency of aberrations
in cells treated with a CHIP dose of 94 ,g ml-l
after which the surviving fraction is 0.1 (Nias et al.,
1979). A relatively low frequency of aberrations
was produced compared with the high cell killing
observed with the same dose of CHIP. Only
chromatid type aberrations were observed. After
the subtraction of control levels of aberrations, a
linear dose-response relationship was found (Figure
1) between chromatid breaks and doses of CHIP
corresponding to the exponential portion of the
survival curve for clone H cells (Nias et al., 1979).
To examine further the mechanism of production
of aberrations by CHIP, the frequency of
aberrations in the cells treated in G1 and G2 phase
with 94 Mg ml- 1 of the drug, was investigated. The
effect of CHIP on the cells treated in G1 phase was
determined using synchronous cell populations.
Mitotic cells were plated (- 1-3 x 105 cells per
flask) and after 1.5h treated with CHIP. Colcemid
was added to the cultures for the last 3h of the
experiment (i.e. between 10th and 13th h of
experiment). Mitotic cells were subsequently shaken
off at the first mitosis after treatment.
Asynchonous populations of cells were used to
determine the effects of CHIP on cells in G2 phase.
Cells were treated with the drug for 1 h and with
colcemid for a further hour. Thereafter, mitotic
Table I Frequency of chromatid aberrations at the first mitosis after treatment of CHO clone H cells with CHIP in
different stages of the cell cycle
Chromatid aberrations per cell
Multi-
Number of Sum of aberration
Cell cycle analysed Isochromatid all cells
Treatment phase mitoses Breaks breaks Gaps Exchanges types (%)
Control Asynchronous 302 0.026 0.043 0.003 0.072
CHIP GI 99 1.109 0.120 0.406 0.120 1.769 8.08
94 g ml-I Mid S 200 0.240 0.155 0.400
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Figure 1 Relationship between the level of chromatid
breaks per cell observed in asynchronous CHO clone
H cells after treatment in mid S phase with increasing
doses of CHIP for 1 h at 37°C.
cells were harvested immediately. Results of these
experiments, i.e. the frequency of aberrations
produced in G, and G2 phases together with the
data for mid-S cells treated with the same
concentrations of CHIP are shown in Table I. In
cells treated in G, phase all types of chromatid
aberrations were produced, breaks and gaps being
in the majority. A much higher incidence of
aberrations was observed in cells exposed to CHIP
in G I phase than in S phase. Many cells with
numerous aberrations and exhibiting scattered
chromosomes, were also noted. Cells treated in G2
phase showed no difference in the level of
chromatid breaks and exchanges from that found in
untreated cells. Only the frequency of gaps was
greater.
Chromosome aberration production by CHIP in
CHO clone 10 cells GI phase
Three different concentrations of CHIP were used
to study the effect of CHIP at two time intervals
after the treatment of CHO clone 10 cells in G1
phase. Results of these investigations are shown in
Table II. Synchronous populations of cells were
used. The experimental protocol was similar to that
described for clone H except for the time of the
harvest of mitotic cells to allow for differences in
the time of CHIP induced mitotic delay. This was
carried out both between 11 and 16h after
synchronization and between 22 and 23 h. Thus, for
a given concentration of CHIP, replicate cultures
were treated with colcemid between 11-14h and
14-16h after synchronization. and also between 22-
25h and 25-28h after synchronization. The first
two and the second two cell harvests were pooled
and the data in Table II give the mean frequency of
aberrations per cell calculated for the two periods
of time, i.e. for 11-16h and 22-28 h after
synchronization.
From Table II it can be seen that the percentage
of cells exhibiting aberrations and the frequency of
aberrations per cell increase with increasing doses
of CHIP. Approximately the same frequency of
aberrations was produced in both the 1st and 2nd
periods of mitotic cell collection after treatment
with a dose of 69.7 Mg ml-l CHIP. However, a
slightly lower frequency of aberrations was found
during the second period after treatment with the
lowest concentration of CHIP. Although this
difference may not be significant, it could be due to
the appearance of a number of cells reaching their
second mitosis after treatment. After the highest
dose of CHIP there were no mitotic figures in these
clone 10 cells during the first period of collection;
during the second period many cells were found to
be too heavily damaged for their mitotic figures to
be analyzed. Endoreduplicated cells were also
observed (-2-3%) during the second period after
treatment with 69.7 and 90.9 jug ml-1 of CHIP. In
the case of clone H cells, some aberration data were
obtainable after the highest dose of CHIP (Table I,
Figure 1) because of the lower sensitivity of these
cells.
Correlation between chromosome aberrations and cell
killing
Figure 2 shows the survival curve for CHO clone
10 cells exposed to CHIP. The parameters of this
curve are: D= 19pgml l, Dq=27pgml-', n=4.1.
The survival of these cells, as a function of lethal
aberrations (i.e. all aberrations per cell excluding
gaps) found at the 1st mitosis after treatment with
CHIP, is presented in Figure 3. There is a log-linear
relationship between aberration frequency and cell
survival, with 0.85 aberrations per cell
corresponding to 37% survival.
Discussion
Mechanism ofaberration production
Data given in Table I show that CHIP induces all
types of chromatid aberrations at the first mitosis
after treatment but only in cells exposed to the
drug in G, and S phases. (The gaps in G2 are of
doubtful significance.) These results suggest that,
with respect to the production of aberrations, CHIP506 E. BOCIAN et al.
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Figure 2 Dose-survival curve obtained after treatment
of CHO clone 10 cells with increasing doses of CHIP
for I h at 370C. Mean values are from 5 experiments
except where single points are drawn (1 experiment
only).
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aberrations per cell (all types excluding gaps) observed
in CHO clone 10 cells at the 1st mitosis after
treatment with CHIP and surviving fraction.
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acts in a similar way to the bifunctional alkylating
agents and to UV light and, therefore, falls into
Class III of Bender's Classification of chemicals.
These are the group of agents producing chromatid
aberrations from drug-induced single strand lesions
delivered in G1-S phase which are expressed during
S phase as a result of DNA synthesis on the
damaged template and are revealed at the first
mitosis thereafter. They are therefore described as
"delayed-type" aberrations (Bender et al., 1974).
A higher incidence of gaps in cells treated with
CHIP in G2 phase, as compared to the control, was
obtained and this is in agreement with the findings
of Bender et al. (1973) and Hittelman & Rao (1974)
who also found that UV light and alkylating agents
produced gaps in G2 treated cells. The nature of
the production of gaps is still not clear, but Bender
et al. (1974) suggested in their general model of
aberration production, that a single polynucleotide
strand break could be manifested at metaphase, as
an achromatic lesion or gap. If this model is
correct, gaps produced by CHIP in G2 phase cells
could be a result of the operation of excision-type
repair processes. Because of the uncertainty about
their contribution to lethality the gap data were
excluded from Figure 3.
Other platinum complexes such as cis-diammine
dichloro platinum (II) (cis-PDD) and cis-
dichlorobis (cyclopentylamine) platinum (II) (PAD)
have also been found to produce chromatid
aberrations of the "delayed type" (Van den Berg &
Roberts, 1975; Szumiel & Nias, 1976; Meyene &
Lockhart, 1978). However, Szumiel and Nias (1976)
showed in the same system of CHO cells that at the
first mitosis after treatment of cells in G1 phase
with PAD no exchanges or isochromatid breaks
were produced. These were only seen at the second
mitosis. The model presenting the mechanism of
action of PAD on chromosomes was given by
Chadwick et al. (1976). It implies that only single
polynucleotide strand breaks opposite damaged
regions are produced during the first DNA
replication after treatment of cells with PAD. This
means that cells are unable to excise lesions in
DNA produced by PAD. According to Bender's
general theory of chromatid aberration production,
chromatid breaks and exchanges arise as a
consequence of the second DNA replication. Thus,
in cells treated with PAD, mainly gaps were seen at
the first mitosis after treatment, and breaks and
exchanges at the second mitosis after treatment
whilst CHIP produced all types of chromatid
aberrations, including isochromatid breaks and
exchanges, at the first mitosis after treatment.
There is evidence for the ability of cells to repair
platinum-induced lesions in DNA (Roberts et al.,
1982). Therefore, the reason for the differences
observed in aberration production by CHIP and
PAD could partly lie in the differing ability of the
cells to excise the lesions induced by the two
platinum complexes which itself might also be
connected with the different type and/or position of
the lesions produced.
Endoreduplicated cells were observed after
treatment with CHIP. It is well known that as a
consequence of the endoreduplication process,
daughter cells frequently receive differing
chromosome complements as a result of non-
disjunction and multipolar divisions and this also
leads to the polyploidisation of cells. It has been
found that endoreduplication can also be induced
in the second and subsequent generations after
treatment of cells with other chemicals such as #
mercapto-ethanol and nitroquinoline-I oxide and
also with x-irradiation (Suton, 1973).
7he frequency of chromosome aberrations and cell
killing
Although there is a well-established relationship
between chromosomal aberrations and radiation-
induced cell death (e.g. Dewey et al., 1978), the
contribution of chromosomal aberrations to cell
lethality induced by chemical agents has been
studied to a much lesser extent (reviewed by Scott,
1977). Platinum compounds were not included in
these studies nor in the quantitative comparison of
cytogenetic effects of x-rays and anti-tumour drugs
by Parkes & Scott (1982). It therefore seemed of
interest to analyze the relationship between the
clonogenic ability of CHIP treated cells and the
frequency of chromosomal aberrations.
These parameters have been determined on
different cell populations; asynchronous for survival
determination by cloning and synchronous (G1) for
analysis of chromatid aberrations. This was
justifiable because of the lack of sensitivity
dependence on cell age (Ackers, 1983). Such a lack
of dependence was found earlier with PAD for
which Szumiel & Nias (1976) also observed no age
dependency ofcytotoxic activity.
The data on chromatid aberration frequency were
taken from Table II. CHIP induced mitotic delay is
dose dependent and this was confirmed by pulse
labelling the synchronous CHO cell population
treated with a dose of CHIP to give a SF of 0.1 as
well as from clone-size analysis for the dose of
CHIP giving survival levels of 0.4 and 0.1
respectively (Ackers, 1983). It was therefore
plausible to assume that the more sensitive clone 10
cells treated with the highest (90.9 Mg ml-1) dose of
CHIP (SF=0.03) did not pass their first mitosis
after treatment at the time interval studied. These
data on aberration frequency have been plotted
with the corresponding survival data in Figure 3.508 E. BOCIAN et al.
As can be seen, survival of CHO cells exposed to
CHIP is log-linearly related to the chromatid
aberration frequency with a level of 0.85
aberrations per cell corresponding to 37% survival.
It was also found that the doses of CHIP reducing
survival of both CHO clone H and clone 10 to a
similar level induce similar frequencies of chromatid
aberrations (Tables I and II and Figure 2-SF=0.1
and 0.13 in CHO clone H and clone 10 respectively,
with corresponding levels of aberrations per cell of
1.77 and 1.71.
A positive correlation between the lethal effects
of PAD and the frequency of chromatid breaks in
two mouse lymphoma L5178Y cell strains, differing
in their sensitivity to PAD, was found by Szumiel
(1979). A similar correlation between sensitivity to
sulphur mustard and x-irradiation with
chromosome aberration frequency in two Yoshida
strains was also observed by Scott et al. (1974). On
the other hand, Parkes & Scott (1982) found no
correlation between the incidence of structural
aberrations and the survival of diploid human
fibroblasts when the effects of x-rays and four other
cytotoxic agents were compared at equitoxic doses.
A log-linear relationship similar to that shown in
Figure 3 between survival and chromatid aberration
frequency was shown in x-irradiated CHO cells by
Dewey et al. (1978). Their results suggested that
only one aberration per cell is required for cell
death and that chromatid type aberrations
appeared to be as lethal as the chromosome type.
So far, there are no satisfactory explanations of
these observations.
Aberrations which affect only one sister
chromatid would be expected to result in 50%
cytologically normal daughter cells after the first
mitosis. This would only be correct for cells which
have one aberration per cell and therefore it would
relate only to those cells treated with the lowest
dose of drug used in this study. The good
correlation between survival and chromatid
aberration frequency may result from a delayed
formation of chromosomal aberrations in cells
originating from the apparently normal first
generation cells. It may also be fortuitous that
other lethal events, not discernible cytologically,
log-linearly related to the drug dose, may increase
the lethality in a manner apparently related to the
aberration frequency. One such event may be that
leading to interphase cell death.
Conclusion
Our experiments here have confirmed that CHIP
can be classified, along with other platinum co-
ordination complexes and bifunctional alkylating
agents, into Class III of Bender's chemical
classification (Bender et al., 1974). Differences
observed in the type of chromatid aberrations
produced by PAD and CHIP, especially at first
mitosis after treatment, suggested differences of
type and position of the lesions induced by the two
compounds in DNA. This in turn could affect the
cells' ability to excise the lesions. We have also
found a log-linear relationship between survival and
the chromatid aberration frequency determined at
first mitosis after treatment.
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